Phospho-Nephrin (Tyr1176 + Tyr1193) Antibody [D21M18]

N° de catalogue F3646

Imprimer

Description biologique

Spécificité Phospho-Nephrin (Tyr1176 + Tyr1193) Antibody [D21M18] détecte les niveaux endogènes de la protéine Nephrin totale uniquement lorsqu'elle est phosphorylée en Tyr1176 et Tyr1193.
Contexte Phospho-Nephrin (Tyr1176 + Tyr1193) fait référence à la néphrine (NPHS1), une glycoprotéine transmembranaire de type I de la superfamille des immunoglobulines qui forme le diaphragme de fente dans les processus podocytaires, essentiel pour la sélectivité de la barrière de filtration glomérulaire. La néphrine comprend un domaine extracellulaire avec 7 domaines de type Ig et 1 domaine de fibronectine III pour l'adhésion homophile/hétérophile (NEPH1), une seule hélice transmembranaire et une queue cytoplasmique contenant trois motifs YDxV conservés, y compris Tyr1176 et Tyr1193, qui, lorsqu'ils sont phosphorylés par la kinase Fyn, servent de sites de liaison SH2 de haute affinité. La phosphorylation en Tyr1176/Tyr1193 recrute les adaptateurs Nck1/2, qui, via les domaines SH3, activent le complexe N-WASP/Arp2/3 pour entraîner la polymérisation localisée de l'actine, liant l'intégrité du diaphragme de fente au remodelage cytosquelettique et maintenant l'architecture/perméabilité des podocytes. Nck améliore l'activité de Fyn, formant une boucle de rétroaction positive amplifiant la phosphorylation ; cette signalisation maintient l'activation basale d'Akt (Thr308/Ser473) pour la survie des podocytes. La déphosphorylation ou les mutations Y1176/1193F altèrent la liaison de Nck, la dynamique de l'actine, la récupération de l'effacement des processus podocytaires après une lésion (modèle au sulfate de protamine), entraînant une protéinurie ; une réduction de p-Tyr1176/1193 est observée dans la néphropathie diabétique, la maladie des changements minimes.

Informations dutilisation

Application WB Dilution
WB
1:10000 - 1:50000
Réactivité Human
Source Rabbit Monoclonal Antibody MW 134 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/31599693/
  • https://pubmed.ncbi.nlm.nih.gov/23188823/

Données dapplication

WB

Validé par Selleck

  • F3646-wb
    Lane 1: HEK293T (myc-tagged human Nephrin transfected), Lane 2: HEK293T (myc-tagged human Nephrin transfected; myc-tagged Src transfected), Lane 3: HEK293T (myc-tagged human Nephrin transfected; myc-tagged Src transfected; phosphatase treated)